RETAGLOBIN Trademark

Trademark Overview

On Monday, February 23, 2015, a trademark application was filed for RETAGLOBIN with the United States Patent and Trademark Office. The USPTO has given the RETAGLOBIN trademark a serial number of 86542685. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 16, 2018. This trademark is owned by Hospira, Inc.. The RETAGLOBIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical drug for the treatment of anemia
retaglobin

General Information

Serial Number86542685
Word MarkRETAGLOBIN
Filing DateMonday, February 23, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 16, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical drug for the treatment of anemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 9, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHospira, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045
Party NameHospira, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045

Trademark Events

Event DateEvent Description
Monday, April 16, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 16, 2018ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 14, 2017EXTENSION 4 GRANTED
Monday, August 14, 2017EXTENSION 4 FILED
Monday, August 14, 2017TEAS EXTENSION RECEIVED
Wednesday, March 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 13, 2017EXTENSION 3 GRANTED
Monday, March 13, 2017EXTENSION 3 FILED
Monday, March 13, 2017TEAS EXTENSION RECEIVED
Wednesday, October 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 18, 2016EXTENSION 2 GRANTED
Tuesday, September 13, 2016EXTENSION 2 FILED
Tuesday, September 13, 2016TEAS EXTENSION RECEIVED
Friday, April 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2016EXTENSION 1 GRANTED
Wednesday, March 9, 2016EXTENSION 1 FILED
Monday, April 11, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 9, 2016TEAS EXTENSION RECEIVED
Wednesday, November 25, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 25, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 15, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, May 30, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 29, 2015ASSIGNED TO EXAMINER
Monday, March 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 26, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

retaglobin anemia treatment drug pharmaceutical